Lansoprazole Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Description

Lansoprazole is an important proton pump inhibitor and a substituted benzimidazole with antisecretory and antiulcer activities. Its mode of action involves the suppression of gastric acid secretion by specific inhibition of the gastric H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cells.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.